MeSH tree: C10.228.140.079
Researchers at Japan's National Institutes for Quantum Science and Technology (QST) have found that tau buildup in progressive supranuclear palsy (PSP) may affect brain networks involved in thinking and behavior. The findings ...
6 hours ago
0
2
Parkinson's disease is the second most common neurodegenerative disease worldwide after Alzheimer's disease and, according to the World Health Organization, one of the fastest-growing neurological disorders. Yet genetic research ...
Jul 16, 2026
0
3
An international team has succeeded in using a magnetic field to target structures deep within the brain. The researchers injected magnetic nanoplatelets into the relevant region. By doing so, they succeeded in treating movement ...
Jul 16, 2026
0
9
Advances in research have identified biomarker tests that make it possible to detect signs of neurodegenerative conditions such as Alzheimer's disease years before symptoms appear, creating new opportunities for earlier intervention—and ...
Jul 15, 2026
0
3
For many people with Parkinson's disease, the body stops moving the way it used to. A hand may tremble at rest. Muscles may stiffen. Walking can become slower and balance more uncertain. The most effective treatment remains ...
Jul 15, 2026
0
5
Disease progression in people with Parkinson's disease can be accurately monitored using sensors, removing some of the limitations of wearable technologies, a new study reports. In the study published in the Journal of NeuroEngineering ...
Jul 13, 2026
0
6
A high-performance biodegradable pressure sensor has been developed as a key technology for wearable AI health care robotics and user-friendly robotic systems.
Jul 9, 2026
0
4
An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington's disease was presented at the ISSCR 2026 Annual Meeting. The Phase Ib/IIa REGEN4HD study represents ...
Jul 9, 2026
0
4
New clinical data from the STEM-PD Phase I/II clinical trial have been presented at the ISSCR 2026 Annual Meeting. The study reports 12-month outcomes evaluating a cryopreserved, off-the-shelf dopaminergic progenitor cell ...
Jul 9, 2026
0
9
Interim clinical findings from the first Phase I/IIa trial using autologous-induced pluripotent stem cell (iPSC)-derived dopamine neuron precursor cells, along with the novel quality-control tools developed to manufacture ...
Jul 9, 2026
0
5
